ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Dr. Reddy's Laboratories Limited (RDY) stock declined over -0.93%, trading at $13.32 on NYSE, down from the previous close of $13.44. The stock opened at $13.37, fluctuating between $13.18 and $13.36 in the recent session.
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. Its Proprietary Products segment focuses on the research and development of differentiated formulations. The Others segment engages in developing therapies in the fields of oncology and inflammation. The therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. The company has a collaboration, license, and option agreement with Curis, Inc. to discover, develop, and commercialize small molecule antagonists for immuno-oncology and precision oncology targets. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
Employees | 27048 |
Beta | 0.37 |
Sales or Revenue | $279.16B |
5Y Sales Change% | 0.729% |
Fiscal Year Ends | March |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Dr. Reddy's Laboratories Limited (NYSE: RDY) stock price is $13.32 in the last trading session. During the trading session, RDY stock reached the peak price of $13.36 while $13.18 was the lowest point it dropped to. The percentage change in RDY stock occurred in the recent session was -0.93% while the dollar amount for the price change in RDY stock was -$0.13.
The NYSE listed RDY is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Dr. Reddy's Laboratories Limited designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Erez Israeli M.B.A.
Chief Executive Officer & Member of the Management Council
Mr. Deepak Sapra M.B.A.
Chief Executive Officer of API & Services & Member of Management Council
Mr. Parag Agarwal
Chief Financial Officer & Member of Management Council
Mr. Sanjay Sharma B.Tech.
Executive Vice President, Global Head of Global Manufacturing & Member of Management Council
Mr. Marc Kikuchi B.A., M.B.A.
Chief Executive Officer of North America Generics & Member of Management Council
Ms. Archana Bhaskar B.Sc., M.B.A.
EVice President, Head of Corporation Communications, Chief HR Officer & Member of Management Council
Mr. Venkata Ramana Motupalli M.B.A., MBA
Chief Executive Officer of Branded Markets - India & Emerging Countries and Member of Management Council
Mr. Patrick Aghanian B.A., M.B.A.
Chief Executive Officer of European Generics & Member of Management Council
Mr. Gunupati Venkateswara Prasad B.E.
Co-Chairman, MD & Member of Management Council
Mr. Kallam Satish Reddy B.Tech., M.S.
Chairman & Member of the Management Council
RDY's closing price is 2.13% higher than its 52-week low of $13.16 where as its distance from 52-week high of $16.89 is -20.44%.
Number of RDY employees currently stands at 27,048.
Official Website of RDY is: https://www.drreddys.com
RDY could be contacted at phone 914 049 002900 and can also be accessed through its website. RDY operates from 8-2-337, Road No. 3, Hyderabad, 500034, India.
RDY stock volume for the day was 481.4K shares. The average number of RDY shares traded daily for last 3 months was 1.84M.
The market value of RDY currently stands at $11.09B with its latest stock price at $13.32 and 833.08M of its shares outstanding.